Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: A clinicopathological comparison between tonsillar and non tonsillar lymphomas
| dc.creator | Economopoulos, T. | en |
| dc.creator | Fountzilas, G. | en |
| dc.creator | Kostourou, A. | en |
| dc.creator | Daniilidis, J. | en |
| dc.creator | Pavlidis, N. | en |
| dc.creator | Andreopoulou, H. | en |
| dc.creator | Nicolaou, A. | en |
| dc.creator | Papageorgiou, E. | en |
| dc.creator | Mellou, S. | en |
| dc.creator | Dervenoulas, J. | en |
| dc.creator | Stathakis, N. | en |
| dc.date.accessioned | 2015-11-23T10:26:03Z | |
| dc.date.available | 2015-11-23T10:26:03Z | |
| dc.date.issued | 1998 | |
| dc.identifier.issn | 2507005 | |
| dc.identifier.uri | http://hdl.handle.net/11615/27272 | |
| dc.description.abstract | Primary extranodal NHL of the head and neck (HN-NHL) accounts for 10-20% of all cases of NHL. Despite their frequency, the natural history and biological behaviour of these lymphomas is poorly understood. In this study we analysed the data 116 cases of HN-NHL. There were 65 males and 51 females with a median age of 56 years. The distribution among different anatomical sites was: tonsils 56 cases (48.3%), nasopharynx 15 (12.9%), mandible/gingiva 9 (7.8%), hard palate 7 (6%), parotis 6 (5.2%), thyroid 5 (4.3%), ocular adnexa 4 (3.5%), paranasal sinuses 2 (1.7%). The patients were treated with radiotherapy alone (14 cases), combined chemotherapy (52 cases) and combined modality (50 cases). According to the WF historical classification 73 cases (62.9%) had intermediate, 32 (27.6%) high and 11 (9.5%) low grade. Patients were separated in two groups: Tonsillar NHL (56 cases) and NHL of all other sites (non-tonsillar group - 60 cases). A comparison between the two groups showed that there was no statistically significant difference with respect to age, sex, and histological subtypes. Also treatment reponse was similar (82.1% for the tonsillar vs 83.3% for the non-tonsillar). The two groups differed in stage distribution, survival and pattern of relapse. Stage I was more frequent in the non-tonsillar NHL (60%) in contrast to tonsillar NHL where stage II was more prominent (51.8%). Median survival was 86 months for the tonsillar while it has not been reached yet for the non-tonsillar group had better survival compared to stages I and II of the tonsillar patients. Finally GI tract was a common site of relapse in the tonsillar group while a considerable number in CNS relapses were observed in the non-tonsillar group. We concluded that HN-NHL constitutes a heterogeneous group of patients. Tonsillar lymphomas represent a distinct group with some special clinicopathological findings. | en |
| dc.source | Anticancer Research | en |
| dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-0032420867&partnerID=40&md5=04aee137864b806890bf2dcd566b77d0 | |
| dc.subject | Head and neck extranodal lymphoma | en |
| dc.subject | Tonsillar lymphoma | en |
| dc.subject | antineoplastic agent | en |
| dc.subject | cyclophosphamide | en |
| dc.subject | doxorubicin | en |
| dc.subject | epirubicin | en |
| dc.subject | mitoxantrone | en |
| dc.subject | prednisone | en |
| dc.subject | vincristine | en |
| dc.subject | adolescent | en |
| dc.subject | adult | en |
| dc.subject | age | en |
| dc.subject | aged | en |
| dc.subject | article | en |
| dc.subject | cancer chemotherapy | en |
| dc.subject | cancer grading | en |
| dc.subject | cancer radiotherapy | en |
| dc.subject | cancer survival | en |
| dc.subject | female | en |
| dc.subject | gender | en |
| dc.subject | gingiva disease | en |
| dc.subject | head and neck cancer | en |
| dc.subject | histology | en |
| dc.subject | human | en |
| dc.subject | human tissue | en |
| dc.subject | hypopharynx cancer | en |
| dc.subject | larynx cancer | en |
| dc.subject | major clinical study | en |
| dc.subject | male | en |
| dc.subject | mandible cancer | en |
| dc.subject | nasopharynx cancer | en |
| dc.subject | nonhodgkin lymphoma | en |
| dc.subject | nose cavity cancer | en |
| dc.subject | palate disease | en |
| dc.subject | parotid gland carcinoma | en |
| dc.subject | pathology | en |
| dc.subject | priority journal | en |
| dc.subject | relapse | en |
| dc.subject | tonsil carcinoma | en |
| dc.subject | Antineoplastic Combined Chemotherapy Protocols | en |
| dc.subject | Combined Modality Therapy | en |
| dc.subject | Disease-Free Survival | en |
| dc.subject | Greece | en |
| dc.subject | Head and Neck Neoplasms | en |
| dc.subject | Humans | en |
| dc.subject | Hydrocortisone | en |
| dc.subject | Lymphoma, Non-Hodgkin | en |
| dc.subject | Methotrexate | en |
| dc.subject | Methylprednisolone | en |
| dc.subject | Middle Aged | en |
| dc.subject | Multivariate Analysis | en |
| dc.subject | Neoplasm Staging | en |
| dc.subject | Prednisolone | en |
| dc.subject | Recurrence | en |
| dc.subject | Survival Rate | en |
| dc.subject | Time Factors | en |
| dc.title | Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: A clinicopathological comparison between tonsillar and non tonsillar lymphomas | en |
| dc.type | journalArticle | en |
Αρχεία σε αυτό το τεκμήριο
| Αρχεία | Μέγεθος | Τύπος | Προβολή |
|---|---|---|---|
|
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο. |
|||

